Use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes

被引：0
|
作者：
Runge, MH [1 ]
Stouffer, GA [1 ]
Sheahan, RG [1 ]
Parmar, R [1 ]
机构：
[1] UNIV TEXAS, MED BRANCH, DEPT MED, DIV CARDIOL, GALVESTON, TX 77555 USA
来源：
AMERICAN JOURNAL OF THE MEDICAL SCIENCES | 1997年 / 314卷 / 01期
关键词：
D O I：
10.1097/00000441-199707000-00007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：31 / 36
页数：6
相关论文
共 50 条
  • [21] Outcomes with the use of glycoprotein IIb/IIIa inhibitors in non-ST-segment elevation acute coronary syndromes
    Dabbous, O. H.
    Anderson, F. A., Jr.
    Gore, J. M.
    Eagle, K. A.
    Fox, K. A. A.
    Mehta, R. H.
    Goldberg, R. J.
    Agnelli, G.
    Steg, P. G.
    [J]. HEART, 2008, 94 (02) : 159 - 165
  • [22] Controversies surrounding platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention and acute coronary syndromes
    Harrington, RA
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2004, 30 (06): : 639 - 647
  • [23] Evaluating the benefits of glycoprotein, IIb/IIIa inhibitors in heart failure at baseline in acute coronary syndromes
    Srichai, MB
    Jaber, WA
    Prior, DL
    Marso, SP
    Houghtaling, PL
    Menon, V
    Simoons, ML
    Harrington, RA
    Hochman, JS
    [J]. AMERICAN HEART JOURNAL, 2004, 147 (01) : 84 - 90
  • [24] Is There Still a Role for Glycoprotein IIb/IIIa Antagonists in Acute Coronary Syndromes?
    Iannetta, Loredana
    Puddu, Paolo Emilio
    Cuturello, Domenico
    Saladini, Angela
    Pellicano, Mariano
    Schiariti, Michele
    [J]. CARDIOLOGY RESEARCH, 2013, 4 (01) : 1 - 7
  • [25] The role of glycoprotein IIb/IIIa inhibition in the management of acute coronary syndromes
    Koller, CF
    [J]. HEART & LUNG, 2001, 30 (05): : 321 - 331
  • [26] Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors
    Freeman, RV
    Mehta, RH
    Al Badr, W
    Cooper, JV
    Kline-Rogers, E
    Eagle, KA
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (05) : 718 - 724
  • [27] Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes
    Braunwald, E
    Maseri, A
    Armstrong, PW
    Califf, RM
    Gibler, WB
    Hamm, CW
    Simoons, ML
    Van de Werf, F
    [J]. AMERICAN HEART JOURNAL, 1998, 135 (04) : S56 - S66
  • [28] Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes
    Braunwald, E
    Maseri, A
    Armstrong, PW
    Califf, RM
    Gibler, WB
    Hamm, CW
    Simoons, ML
    Van de Werf, F
    [J]. EUROPEAN HEART JOURNAL, 1998, 19 : D22 - D30
  • [29] The TRACS score predicts benefit of upstream glycoprotein IIb/IIIa use in acute coronary syndromes
    Nathan, Sandeep
    Amin, Amit P.
    Calvin, James E., Jr.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A199 - A200
  • [30] Trends of Use and Outcomes Associated With Glycoprotein-IIb/IIIa Inhibitors in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
    Gellatly, Rochelle M.
    Connell, Cia
    Tan, Christianne
    Andrianopoulos, Nick
    Ajani, Andrew E.
    Clark, David J.
    Nanayakkara, Shane
    Sebastian, Martin
    Brennan, Angela
    Freeman, Melanie
    O'Brien, Jessica
    Selkrig, Laura A.
    Reid, Christopher M.
    Duffy, Stephen J.
    [J]. ANNALS OF PHARMACOTHERAPY, 2020, 54 (05) : 414 - 422
12345